Testing a Meditation App With Justice-Involved Youth on Probation (Project AIM)

January 9, 2023 updated by: Ashley D Kendall, University of Illinois at Chicago

Reducing HIV/Sexually Transmitted Infection (STI) Risk Behaviors Among Juvenile Offenders on Probation: A Mobile Mindfulness-Based Intervention

This study is a randomized controlled trial (RCT) testing the effects of a mindfulness-based intervention delivered to justice-involved youth on probation via smartphone app on youths' emotion regulation and HIV/sexually transmitted infection (STI) risk-taking behaviors (i.e., alcohol use, cannabis use, sexual behaviors, and aggressive behaviors).

Study Overview

Detailed Description

The investigators will enroll 200 justice-involved youth on probation 13-18 years old of all genders who report regular access to an Apple or Android smartphone. Following completion of a baseline questionnaire, participants will be individually randomized at a 1:1 ratio to 1 of 2 smartphone app conditions: (1) Bodhi AIM (Action In Mindfulness), a 30-day mindfulness-based intervention, or (2) HIB (Health In Balance), a health promotion control app matched to Bodhi AIM for time and structure. Follow-up assessments will occur at 1 and 6 months.

Study Type

Interventional

Enrollment (Anticipated)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Ashley D Kendall, PhD
  • Phone Number: (312) 355-1836
  • Email: akendall@uic.edu

Study Locations

    • Illinois
      • Chicago, Illinois, United States, 60612
        • Recruiting
        • University of Illinois at Chicago
        • Contact:
        • Principal Investigator:
          • Ashley D Kendall, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

13 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 13-18 years old
  • On probation in the Chicago Cook County Juvenile Justice System

Exclusion Criteria:

  • Unable to understand the permission/consent/assent process
  • Do not speak English, due to norming of instruments
  • Do not assent/consent
  • Legal guardian does not give permission for youth's participation if under 18 years old
  • Do not have an Apple or Android phone
  • Are detained
  • Are in care of DCFS

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Bodhi AIM
Participants randomized to the intervention group will receive the Bodhi AIM app
Bodhi AIM (Action In Mindfulness) is a smartphone-based app that teaches users to establish a daily meditation practice via a 30-day "path," with each day consisting of a brief audio- or video-guided file. In addition to the 30 daily path files, users have access to a menu of "to go" audio-guided meditation practices that they may access any time to prepare for particular situations (e.g., attending a party).
Active Comparator: HIB
Participants randomized to the health promotion control group will receive the HIB app
HIB (Health In Balance) is a smartphone-based app that is matched to Bodhi AIM for time and structure, but includes health promotion content (e.g., educational information on substance use) in place of the meditation content featured in Bodhi AIM. Like Bodhi AIM, HIB includes a 30-day "path" of audio and video files, along with a menu of "to go" audio files that users may access any time to review key intervention concepts.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in Negative Emotion Regulation
Time Frame: Baseline, 1-month follow-up, 6-month follow-up
Changes in Negative Emotion Regulation as measured by the Negative Mood Regulation Scale [At baseline, 1-month follow-up, and 6-month follow-up]
Baseline, 1-month follow-up, 6-month follow-up
Changes in Alcohol Use
Time Frame: Baseline, 1-month follow-up, 6-month follow-up
Changes in Alcohol Use as measured by the Young Adult Alcohol Problem Scale [6-month time period at baseline, 1-month time period at 1-month follow-up, 6-month time period at 6-month follow-up]
Baseline, 1-month follow-up, 6-month follow-up
Changes in Cannabis Use
Time Frame: Baseline, 1-month follow-up, 6-month follow-up
Changes in Cannabis Use as measured by the Cannabis Use Disorders Identification Test - Revised [6-month time period at baseline, 1-month time period at 1-month follow-up, 6-month time period at 6-month follow-up]
Baseline, 1-month follow-up, 6-month follow-up
Changes in Sexual Behavior
Time Frame: Baseline, 1-month follow-up, 6-month follow-up
Changes in Sexual Behavior as measured by a modified version of the AIDS Risk Behavior Assessment [6-month time period at baseline, 1-month time period at 1-month follow-up, 6-month time period at 6-month follow-up]
Baseline, 1-month follow-up, 6-month follow-up
Changes in Aggression
Time Frame: Baseline, 1-month follow-up, 6-month follow-up
Changes in Aggression as measured by the Reactive-Proactive Aggression Questionnaire [At baseline, 1-month follow-up, and 6-month follow-up]
Baseline, 1-month follow-up, 6-month follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in Positive Emotion Regulation
Time Frame: Baseline, 1-month follow-up, 6-month follow-up
Changes in Positive Emotion Regulation as measured by the Connor-Davidson Resilience Scale 10 [1-month time period at baseline, 1-month follow-up, and 6-month follow-up]
Baseline, 1-month follow-up, 6-month follow-up
Changes in Mindfulness
Time Frame: Baseline, 1-month follow-up, 6-month follow-up
Changes in Mindfulness as measured by the Five Facets of Mindfulness Questionnaire [At baseline, 1-month follow-up, and 6-month follow-up]
Baseline, 1-month follow-up, 6-month follow-up
Changes in Alcohol Trouble
Time Frame: Baseline, 1-month follow-up, 6-month follow-up
Changes in Alcohol Trouble as measured by the Alcohol Trouble Scale [6-month time period at baseline, 1-month time period at 1-month follow-up, 6-month time period at 6-month follow-up]
Baseline, 1-month follow-up, 6-month follow-up
Changes in Hangover Symptoms
Time Frame: Baseline, 1-month follow-up, 6-month follow-up
Changes in Hangover Symptoms as measured by the Hangover Symptoms Scale [6-month time period at baseline, 1-month time period at 1-month follow-up, 6-month time period at 6-month follow-up]
Baseline, 1-month follow-up, 6-month follow-up
Changes in Substance Use Attitudes and Beliefs
Time Frame: Baseline, 1-month follow-up, 6-month follow-up
Changes in Substance Use Attitudes and Beliefs as measured by a modified version of the Alcohol Abstinence Self-Efficacy Scale [At baseline, 1-month follow-up, and 6-month follow-up]
Baseline, 1-month follow-up, 6-month follow-up
Changes in Additional Facets of Aggression
Time Frame: Baseline, 1-month follow-up, 6-month follow-up
Changes in Additional Facets of Aggression as measured by the Short-Form Buss-Perry Aggression Questionnaire [At baseline, 1-month follow-up, and 6-month follow-up]
Baseline, 1-month follow-up, 6-month follow-up
Changes in Mental Health Symptoms
Time Frame: Baseline, 1-month follow-up, 6-month follow-up
Changes in Mental Health Symptoms as measured by the Youth Self-Report (YSR) [6-month time period at baseline, 1-month time period at 1-month follow-up, 6-month time period at 6-month follow-up]
Baseline, 1-month follow-up, 6-month follow-up
Changes in Trauma Symptoms
Time Frame: Baseline, 1-month follow-up, 6-month follow-up
Changes in Trauma Symptoms as measured by the UCLA PTSD Rating Index [1-month time period at baseline, 1-month follow-up, and 6-month follow-up]
Baseline, 1-month follow-up, 6-month follow-up
App Usage
Time Frame: Up through 6-month follow-up
App Usage as assessed by objective app usage data (date/time stamps for each app feature) [Up through 6-month follow-up]
Up through 6-month follow-up
Digital Working Alliance
Time Frame: 1-month follow-up
Digital Working Alliance as measured by the Digital Working Alliance Inventory [At 1-month follow-up]
1-month follow-up
Juvenile Justice Involvement
Time Frame: Baseline, 1-month follow-up, 6-month follow-up
Juvenile Justice Involvement (i.e., number of arrests, charge(s), number of detainments) [Lifetime time period at baseline, 1-month time period at 1-month follow-up, 6-month time period at 6-month follow-up]
Baseline, 1-month follow-up, 6-month follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ashley D Kendall, PhD, University of Illinois at Chicago

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 5, 2022

Primary Completion (Anticipated)

February 28, 2024

Study Completion (Anticipated)

February 28, 2024

Study Registration Dates

First Submitted

November 8, 2021

First Submitted That Met QC Criteria

November 23, 2021

First Posted (Actual)

December 6, 2021

Study Record Updates

Last Update Posted (Estimate)

January 11, 2023

Last Update Submitted That Met QC Criteria

January 9, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2018-0889
  • R00DA047890 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

De-identified data may be placed in one or more electronic databases which could be used for other research studies.

IPD Sharing Time Frame

Data sharing will generally coincide with publication of the study's main findings and is intended to take place within 1 year after acceptance of the primary manuscripts.

IPD Sharing Access Criteria

To be determined

IPD Sharing Supporting Information Type

  • Study Protocol

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Aggression

Clinical Trials on Bodhi AIM (intervention group)

3
Subscribe